Can dietetic intervention for obesity ever succeed in real life?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 4, 2007, Pages 459-460

  Chan, Henry L Y ^a,b   Wong, Vincent W S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GLITAZONE DERIVATIVE; METFORMIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIET THERAPY; DOCTOR PATIENT RELATION; EDITORIAL; FATTY LIVER; HEALTH CARE COST; HEPATITIS C; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIVER FIBROSIS; LOW CARBOHYDRATE DIET; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 33947282828     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04931.x     Document Type: Editorial

References (16)

1. He J, Gu D, Wu X et al. Major causes of death among men and women in China. N. Engl. J. Med. 2005; 353: 1124-34.
2. Wong VW, Hui AY, Tsang SW et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2006; 4: 1154-61.
3. Wong VW, Hui AY, Tsang SW et al. Prevalence of undiagnosed diabetes and postchallenge hyperglycemia in Chinese patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2006; 24: 1215-22.
4. Adams LA, Lymp JF, St Sauver J et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-21.
5. Leandro G, Mangia A, Hui J et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 2006; 130: 1636-42.
6. Conjeevaram HS, Kleiner DE, Everhart JE et al. Race, insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology 2007; 45: 80-7.
7. Lai MS, Hsieh MS, Chiu YH, Chen YH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006; 43: 1295-302.
8. Cinar K, Coban S, Idilman R. et al. Long-term prognosis of nonalcoholic fatty liver disease: is pharmacological therapy actually necessary? J. Gastroenterol. Hepatol. 2006; 21: 169-73.
9. Chan HL, de Silva HJ, Leung NW et al. How should we manage patients with non-alcoholic liver disease in 2007? J. Gastroenterol. Hepatol. 2007 (in press).
10. Belfort R, Harrison SA, Brown K et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 2006; 355: 2297-307.
11. Samaha FF, Igbal N, Seshadri P et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N. Engl. J. Med. 2003; 348: 2074-81.
12. Osland EJ, Powell EE, Banks M, Jonsson JR, Hickman IJ. Obesity management in liver clinics: translation of research into clinical practice. J. Gastroenterol. Hepatol. 2007; 22: 504-9.
13. Wong VW, Chan HL, Hui AY et al. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese. Aliment. Pharmacol. Ther. 2004; 20: 45-9.
14. Hui AY, Wong VW, Chan HL et al. Histological progression of non-alcoholic fatty liver disease in Chinese patients. Aliment. Pharmacol. Ther. 2005; 21: 407-13.
15. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
16. Furuya CK, de Oliveira CPMS, de Mello ES et al. Effects of bariatric surgery in nonalcoholic fatty liver disease: Preliminary findings after 2 years. J. Gastroenterol. Hepatol. 2007; 22: 510-4.